Biomedical Firms Merger Makes Programming Cells Easier
Source: Streetwise Reports  (7/26/22)
Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million. More >

Monkeypox Virus Test Could Yield Revenue for Its Creator
  (5/31/22)
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report. More >

FDA Approves New Skin Resurfacing Device
Source: Streetwise Reports  (5/26/22)
Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures. More >

Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Source: Streetwise Reports  (5/6/22)
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDDâ„¢s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery." More >

Is Reliq Health Technologies a Nutrimental 'Buy'?
Source: Clive Maund  (4/29/22)
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'. More >

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge
  (3/1/22)
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report. More >

Imaging Diagnostics Co.'s Shares Rise 35% on FY21 Earnings
Source: Streetwise Reports  (2/24/22)
Lantheus Holdings Inc. shares traded to a new 52-week high after the firm reported Q4/21 and FY/21 financial results that included a 25.3% increase in annual revenue. The firm also advised that the FDA approved the sNDA for its isolator-based drug manufacturing facility for diagnostic ultrasound enhancing agent DEFINITY® for patients in the U.S. with suboptimal echocardiograms. More >

Dialysis Equip. Co. Posts Record FY21 Sales
Source: Streetwise Reports  (2/17/22)
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million. More >

FDA Approves First Tubeless Insulin Delivery Device
Source: Streetwise Reports  (1/28/22)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone. More >

Biotech Could Launch Trial of Polyp Screening Test in March
  (1/18/22)
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report. More >

Co.'s COVID-19 Test Detects Omicron Variant
  (12/30/21)
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant. More >

Contakt World Technologies Partnership Will Help Satisfy Demand for Vaccine Passport Technology
Source: Streetwise Reports  (11/12/21)
Contakt World plans to build a diversified health technology SaaS platform and address inequity of health access through technology. More >

Robotic Surgical Systems Co.'s Shares Gain 21% on Q3 Earnings and Forward Revenue Outlook
Source: Streetwise Reports  (11/11/21)
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22. More >

Robotic Surgical Device Maker's Shares Maneuver Higher on Q3 Earnings
Source: Streetwise Reports  (11/4/21)
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue. More >

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
Source: Streetwise Reports  (10/5/21)
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. More >

Telemedicine Tech Firm Poised to Generate $11 Million of Revenue
Source: Streetwise Reports  (9/24/21)
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic. More >

Inotiv Makes $545 Million Bid for Envigo RMS Holdings to Fortify Research and Drug Discovery Platforms
Source: Streetwise Reports  (9/21/21)
Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million which will serve to create a one-stop-shop, discovery-to-approval solution for drug developers. More >

Reliq Health Technologies Rides Telehealth Reimbursement Wave
Source: Streetwise Reports  (9/2/21)
Global telemedicine company will turn a profit in the current quarter and experience rapid growth after new contracts to provide chronic care management and medicare and medicaid reimbursements expand. More >

Liquid Avatar Unveils New App to Confirm COVID-19 Testing Status, Reduce New Outbreaks of the Pandemic
Source: Streetwise Reports  (8/11/21)
The Liquid Avatar Credential Ecosystem, or LAVCE, is designed to carry a secure, digital record of a person’s verifiable COVID-19 testing credentials, and future healthcare applications of the technology are expected. More >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook
Source: Streetwise Reports  (7/16/21)
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. More >

Biotech Firm Confirms 100% Accuracy of COVID-19 Mutation Assays
Source: Streetwise Reports  (6/2/21)
Applied DNA Sciences' SARS-CoV-2 mutation panel and its validation are discussed in a ROTH Capital Partners report. More >

Twist Bioscience Shares Wind Higher After Firm Posts 62% YoY Increase in Q2 Revenue
Source: Streetwise Reports  (5/7/21)
Shares of Twist Bioscience Corp. traded 14% higher after the firm reported that orders in Q2/21 grew by 69% year-over-year and that it is raising its FY/21 revenue guidance to $121–129 million. More >

Nano-X Imaging Receives Go Ahead from FDA for Single Source Digital X-Ray
Source: Streetwise Reports  (4/5/21)
Shares of Nano-X Imaging Ltd. traded 17% higher after the company reported that the FDA has granted 510(k) approval for its single source ARC digital x-ray. More >

RadNet Shares Rise 17% on Record Q4 Revenue and Bright Outlook for 2021
Source: Streetwise Reports  (3/8/21)
Shares of RadNet Inc. reached a new 52-week high after the diagnostic imaging company reported record revenue and adjusted EBITDA for Q4/21 and offered positive financial guidance for FY/21. More >

FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform
Source: Streetwise Reports  (3/3/21)
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures. More >